ArticleBiomedical engineering letters2023
Blood pressure estimation and its recalibration assessment using wrist cuff blood pressure monitor.
Article in Biomedical engineering letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 8 citations in OpenAlex.
- Wearable Hyperspectral Photoplethysmography Allows Continuous Monitoring of Exercise-Induced Hypertension.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Clinical Performance Evaluation of an Artificial Intelligence-Powered Amyloid Brain PET Quantification Method.Nuclear medicine and molecular imaging · 2024Article
- DeepAVP-TPPred: identification of antiviral peptides using transformed image-based localized descriptors and binary tree growth algorithm.Bioinformatics (Oxford, England) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid evolution of wearable technology in healthcare sectors has created the opportunity for people to measure their blood pressure (BP) using a smartwatch at any time during their daily activities. Several commercially-available wearable devices have recently been equipped with a BP monitoring feature. However, concerns about recalibration remain. Pulse transit time (PTT)-based estimation is required for initial calibration, followed by periodic recalibration. Recalibration using arm-cuff BP monitors is not practical during everyday activities. In this study, we investigated recalibration using PTT-based BP monitoring aided by a deep neural network (DNN) and validated the performance achieved with more practical wrist-cuff BP monitors. The PTT-based prediction produced a mean absolute error (MAE) of 4.746 ± 1.529 mmHg for systolic blood pressure (SBP) and 3.448 ± 0.608 mmHg for diastolic blood pressure (DBP) when tested with an arm-cuff monitor employing recalibration. Recalibration clearly improved the performance of both DNN and conventional linear regression approaches. We established that the periodic recalibration performed by a wrist-worn BP monitor could be as accurate as that obtained with an arm-worn monitor, confirming the suitability of wrist-worn devices for everyday use. This is the first study to establish the potential of wrist-cuff BP monitors as a means to calibrate BP monitoring devices that can reliably substitute for arm-cuff BP monitors. With the use of wrist-cuff BP monitoring devices, continuous BP estimation, as well as frequent calibrations to ensure accurate BP monitoring, are now feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.